Article

OTC MEVACOR GETS THUMBS DOWN AGAIN-January 2008

Merck & Co Inc's third bid

Related Videos
Duloxetine for Patients with COPD Suffering from Comorbid Depression
Enhancing Standards for Ethical Responsibilities within Clinical Research
Related Content
Stephen Schworer, MD, PhD | Credit: American Lung Association
January 20th 2025

Small Airway Mucus Plugging in Severe Asthma: Insights and Implications

Stephen Schworer, MD, PhD
Default thumbnail for The Medical Sisterhood podcast
January 16th 2025

Medical Sisterhood: Polished and Powerful—Women Leading the Charge in Advocacy

Mona Shahriari, MD, FAAD Shadi Kourosh, MD, MPH
Abebaw Yohannes, MSc, PhD | Credit: American Lung Association
January 20th 2025

Exploring Duloxetine for Depression in COPD: A Pilot Study

Abebaw Yohannes, MSc, PhD
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes | Image Credit: HCPLive
January 16th 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
ONS-5010 for Wet AMD Secures Noninferiority in NORSE EIGHT Trial | Image Credit: Wills Eye Hospital
January 19th 2025

ONS-5010 for Wet AMD Secures Noninferiority in NORSE EIGHT Trial

Connor Iapoce
Increased Cumulative Isotretinoin Doses Linked to Lower Acne Relapse Rates
January 18th 2025

Increased Cumulative Isotretinoin Doses Linked to Lower Acne Relapse Rates

Tim Smith
© 2025 MJH Life Sciences

All rights reserved.